-
No compromise on rigorous evaluation for vaccine candidates: Scientific Advisor VijayRaghavan
expresspharma
July 13, 2020
India's drug regulator has given the go-ahead for trials for two vaccine candidates -- Bharat Biotech vaccine and the Zydus Cadila vaccine.
-
‘Indiscriminate use of remdesivir, tocilizumab on Covid patients can cause more harm than good’
expresspharma
July 13, 2020
It said the pursuit of an effective treatment for COVID-19 has resulted in repurposing of several drugs which are not part of the main Clinical Management Protocol but have been indicated as investigational therapies.
-
ICMR-Bharat Biotech to expedite clinical trials of COVID-19 vaccine, plan launch by August 15
expresspharma
July 03, 2020
Presently, 12 clinical trial sites have been identified and ICMR has asked the institutions to enable subject enrolment by the first week of July.
-
Remdesivir, tocilizumab and CPT included in revised protocols for COVID-19 clinical management
expresspharma
June 15, 2020
Hydroxychloroquine can be prescribed in the early stages of COVID-19 infection but not for patients with severe disease, use of azithromycin has been discontinued.
-
ICMR teams up with Bharat Biotech to develop COVID-19 vaccine
expresspharma
May 12, 2020
The vaccine will be developed using the virus strain isolated at the ICMR’s National Institute of Virology (NIV), Pune, a statement said.
-
The US and India are collaborating for three potential COVID-19 vaccines: Taranjit Sandhu
expresspharma
May 11, 2020
He also stated that India has an important role to play in these times of crisis as a global supplier of medicines.
-
Sesderma Laboratories communicates the effectiveness of Lactyferrin Forte Solution in the prevention and treatment of COVID-19 infection
expresspharma
April 13, 2020
Sesderma, a Spanish company specializes in Nanotechnology, has managed to produce an effective drug named Lactyferrin (LF) to counter the COVID-19 strain.
-
Vaccine trial launched by ICMR to prevent TB spread
expresspharma
July 18, 2019
The Indian Council of Medical Research launched a vaccine trial to prevent occurrence of TB among close contacts of a TB case (patient). This vaccine trial is an important step in prevention and decreasing the burden of this disease.
-
ICMR signs MoU with FICCI
expressbpd
November 21, 2017
The Federation of Indian Chambers of Commerce and Industry (FICCI) has signed an MoU with Indian Council of Medical Research (ICMR) for Health Technology Accelerated Commercialization (H:TAC) Program.
-
ICMR releases guidelines on biomedical and health research involving children and adult participants
expressbpd
October 16, 2017
The guidelines are aimed to protect and safeguard the interests of individuals, communities and society as a whole